Molecular targeting of prostate cancer cells by a triple drug combination down-regulates integrin driven adhesion processes, delays cell cycle progression and interferes with the cdk-cyclin axis

Peer Review reports

Original Submission
14 Jan 2011	Submitted	Original manuscript
30 Mar 2011	Reviewed	Reviewer Report - Walburgis Brenner
16 Jun 2011	Reviewed	Reviewer Report - mark schrader
1 Aug 2011	Author responded	Author comments - Roman Blaheta
Resubmission - Version 2
1 Aug 2011	Submitted	Manuscript version 2
22 Aug 2011	Author responded	Author comments - Roman Blaheta
Resubmission - Version 3
22 Aug 2011	Submitted	Manuscript version 3
23 Aug 2011	Author responded	Author comments - Roman Blaheta
Resubmission - Version 4
23 Aug 2011	Submitted	Manuscript version 4
Resubmission - Version 5
	Submitted	Manuscript version 5
24 Aug 2011	Author responded	Author comments - Roman Blaheta
Resubmission - Version 6
24 Aug 2011	Submitted	Manuscript version 6
Publishing
25 Aug 2011	Editorially accepted
25 Aug 2011	Article published	10.1186/1471-2407-11-375

Back to article page